NCT02289508

Brief Summary

Objective: The Ultrasonic Cardiac Output Monitor (USCOM) is a non-invasive, quantitative method for measuring and monitoring cardiovascular haemodynamic parameters in patients. The aims of this study are:

  1. 1.To investigate whether USCOM-derived haemodynamic parameters such as Cardiac output (CO), inotropy and oxygen delivery (DO2) have a role in the diagnosis of patients with a compensated heart failure syndrome (cHFS) or acute decompensated heart failure syndrome (adHFS)
  2. 2.To investigate whether USCOM-derived haemodynamic parameters such as CO, inotropy and DO2 correlate with heart failure staging, especially New York Heart Association (NYHA) class and American Heart Association (AHA) stage.
  3. 3.To investigate whether USCOM-derived haemodynamic parameters such as velocity time interval (vti), stroke volume (SV), CO, SV index (SVI), CO index (CI), inotropy and DO2 correlate with ejection fraction.
  4. 4.To investigate whether USCOM-derived haemodynamic variables may be used as prognostic indicators of 30-day, 6-month and 1-year Major Adverse Cardiac Events (MACE).
  5. 5.To evaluate the agreement between hemodynamic measurements obtained using the Ultrasonic Cardiac Output Monitor (USCOM®; USCOM Ltd., Sydney, Australia), and reference standards as determined by 2 Dimensional echocardiography (2D-echo) measurements in groups of haemodynamically stable and unstable adult patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
242

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2014

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2014

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

November 6, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 13, 2014

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 6, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 6, 2018

Completed
Last Updated

February 7, 2018

Status Verified

February 1, 2018

Enrollment Period

3.3 years

First QC Date

November 6, 2014

Last Update Submit

February 6, 2018

Conditions

Keywords

Heart FailureHemodynamicsEchocardiographyDiagnostic techniques and proceduresUltrasonographyUSCOM

Outcome Measures

Primary Outcomes (1)

  • Difference in mean (SD) inotropy between New York Heart Association (NYHA) stages I, II, III and IV

    Inotropy = (Potential energy + kinetic energy) divided by BSA; measured at aortic and pulmonary window by USCOM; units W/m2

    On Day 1

Secondary Outcomes (5)

  • Difference in mean (SD) vti, FTc, SV, SVI, CO, CI, MD, SVR, SVRI, SVV, DO2, DO2I, Inotropy and ejection fraction

    On Day 1

  • Difference in mean (SD) vti, FTc, SV, SVI, CO, CI, MD, SVR, SVRI, SVV, DO2, DO2I, Inotropy and AHA stage

    On Day 1

  • Agreement between CO and SV measured separately by USCOM and 2D-Echo

    On Day 1

  • Number of subjects with and without Major Adverse Cardiac Events (MACE).

    30-days, 6-months and 1-year

  • Number of subjects with and without acute decompensated heart failure syndrome (adHFS)

    On Day 1

Study Arms (4)

acute decompensated heart failure

Patients who fulfill Framingham criteria will be classified as acute decompensated heart failure (adHF). For this study we define this as an acute change in symptoms and signs within the previous 24 hours. When symptoms gradually deteriorate between one day and one month, it is described as gradual decompensated heart failure (gdHF). Some patients may have both.

Device: Ultrasonic cardiac output monitorDevice: Echocardiography

compensated heart failure

compensated heart failure (cHF) is defined as the existence of heart failure in the absence of any acute exacerbation but which may either include typical chronic symptoms and signs or may be asymptomatic but with evidence of cardiac dysfunction i.e. a reduced ejection fraction.

Device: Ultrasonic cardiac output monitorDevice: Echocardiography

non-heart failure patients

Non-heart failure patients (nHFp) are a patient control group with suspected heart failure but who after further assessment are found not to meet the criteria. Such patients may subsequently be found to have COPD, anaemia, over transfusion. As the purpose of this study is to assess the potential value of USCOM parameters in the assessment of patients with possible heart failure in the clinical setting, it is important to include patients without heart failure.

Device: Ultrasonic cardiac output monitorDevice: Echocardiography

healthy controls

Healthy controls are subjects with not acute or chronic illness.

Device: Ultrasonic cardiac output monitor

Interventions

An Ultrasonic Cardiac Output Monitor, a non-invasive Doppler ultrasonography, is capable of measuring haemodynamic parameters non-invasively and appears to be simple and rapid to use, portable, relatively inexpensive and has less potential complications compared with the standard technique, pulmonary artery thermodilution (PATD). It has been compared favorably with a wide range of standard techniques, including PATD, with good interobserver reliability. USCOM may help on monitoring HF and suggesting proper treatment in order to reduce the mortality of adHF.

Also known as: USCOM
acute decompensated heart failurecompensated heart failurehealthy controlsnon-heart failure patients

2D-echo is a conventional standard-of-care tool for non-invasive hemodynamic assessments in adults. The use of 2D-echo requires highly trained personnel, and assessments may take anywhere between 30-45 minutes. It is used to find out the ejection fraction and to compare the haemodynamic parameters with USCOM in this study.

Also known as: Echo
acute decompensated heart failurecompensated heart failurenon-heart failure patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients will be screened and recruited from adult patients either scheduled for elective 2D-echo at a cardiology clinic at the Prince of Wales Hospital, or attending the emergency department at the Prince of Wales Hospital.

You may qualify if:

  • Age ≥ 18 years, AND
  • Written informed consent by patient or nearest relative where appropriate, AND Either
  • Referred for echocardiography, OR
  • At least one typical symptom and one typical sign consistent with possible heart failure, OR
  • Healthy volunteers

You may not qualify if:

  • Age \<18 years
  • Prior enrollment in study
  • Patients with known or suspected pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prince of Wales Hospital

Hong Kong, China

Location

Related Publications (24)

  • McMurray JJ, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart. 2000 May;83(5):596-602. doi: 10.1136/heart.83.5.596. No abstract available.

    PMID: 10768918BACKGROUND
  • Mendez GF, Cowie MR. The epidemiological features of heart failure in developing countries: a review of the literature. Int J Cardiol. 2001 Sep-Oct;80(2-3):213-9. doi: 10.1016/s0167-5273(01)00497-1.

    PMID: 11578717BACKGROUND
  • Sanderson JE, Tse TF. Heart failure: a global disease requiring a global response. Heart. 2003 Jun;89(6):585-6. doi: 10.1136/heart.89.6.585. No abstract available.

    PMID: 12748201BACKGROUND
  • Hung YT, Cheung NT, Ip S, Fung H. Epidemiology of heart failure in Hong Kong, 1997. Hong Kong Med J. 2000 Jun;6(2):159-62.

    PMID: 10895138BACKGROUND
  • Peacock WF. Acute Emergency Department management of heart failure. Heart Fail Rev. 2003 Oct;8(4):335-8. doi: 10.1023/a:1026187013370.

    PMID: 14574053BACKGROUND
  • Peacock WF. Heart failure management in the emergency department observation unit. Prog Cardiovasc Dis. 2004 Mar-Apr;46(5):465-85. doi: 10.1016/j.pcad.2003.12.004.

    PMID: 15179633BACKGROUND
  • Burkhardt J, Peacock WF, Emerman CL. Predictors of emergency department observation unit outcomes. Acad Emerg Med. 2005 Sep;12(9):869-74. doi: 10.1197/j.aem.2005.03.534.

    PMID: 16141022BACKGROUND
  • Peacock WF. Using the emergency department clinical decision unit for acute decompensated heart failure. Cardiol Clin. 2005 Nov;23(4):569-88, viii. doi: 10.1016/j.ccl.2005.08.014.

    PMID: 16278126BACKGROUND
  • Silver MA, Peacock WF 4th, Diercks DB. Optimizing treatment and outcomes in acute heart failure: beyond initial triage. Congest Heart Fail. 2006 May-Jun;12(3):137-45. doi: 10.1111/j.1527-5299.2006.05413.x.

    PMID: 16760699BACKGROUND
  • Kosowsky JM, Gasaway MD, Hamilton CA, Storrow AB. Preliminary experience with an emergency department observation unit protocol for heart failure. Acad Emerg Med. 2000 Oct;7(10):1171.

    PMID: 11015282BACKGROUND
  • Sanderson JE, Chan SK, Chan WW, Hung YT, Woo KS. The aetiology of heart failure in the Chinese population of Hong Kong--a prospective study of 730 consecutive patients. Int J Cardiol. 1995 Aug;51(1):29-35. doi: 10.1016/0167-5273(95)02398-g.

    PMID: 8522394BACKGROUND
  • Diercks DB, Peacock WF, Kirk JD, Weber JE. ED patients with heart failure: identification of an observational unit-appropriate cohort. Am J Emerg Med. 2006 May;24(3):319-24. doi: 10.1016/j.ajem.2005.11.014.

    PMID: 16635705BACKGROUND
  • Juan A, Salazar A, Alvarez A, Perez JR, Garcia L, Corbella X. Effectiveness and safety of an emergency department short-stay unit as an alternative to standard inpatient hospitalisation. Emerg Med J. 2006 Nov;23(11):833-7. doi: 10.1136/emj.2005.033647.

    PMID: 17057132BACKGROUND
  • Kirkpatrick JN, Vannan MA, Narula J, Lang RM. Echocardiography in heart failure: applications, utility, and new horizons. J Am Coll Cardiol. 2007 Jul 31;50(5):381-96. doi: 10.1016/j.jacc.2007.03.048. Epub 2007 Jul 13.

    PMID: 17662389BACKGROUND
  • Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ, Tajik AJ, Seward JB. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function--a study in normals and dilated cardiomyopathy. J Cardiol. 1995 Dec;26(6):357-66.

    PMID: 8558414BACKGROUND
  • Kass DA, Maughan WL, Guo ZM, Kono A, Sunagawa K, Sagawa K. Comparative influence of load versus inotropic states on indexes of ventricular contractility: experimental and theoretical analysis based on pressure-volume relationships. Circulation. 1987 Dec;76(6):1422-36. doi: 10.1161/01.cir.76.6.1422.

    PMID: 3454658BACKGROUND
  • Lam LL, Cameron PA, Schneider HG, Abramson MJ, Muller C, Krum H. Meta-analysis: effect of B-type natriuretic peptide testing on clinical outcomes in patients with acute dyspnea in the emergency setting. Ann Intern Med. 2010 Dec 7;153(11):728-35. doi: 10.7326/0003-4819-153-11-201012070-00006.

    PMID: 21135296BACKGROUND
  • McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A; ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012 Jul;33(14):1787-847. doi: 10.1093/eurheartj/ehs104. Epub 2012 May 19. No abstract available.

    PMID: 22611136BACKGROUND
  • Dey I, Sprivulis P. Emergency physicians can reliably assess emergency department patient cardiac output using the USCOM continuous wave Doppler cardiac output monitor. Emerg Med Australas. 2005 Jun;17(3):193-9. doi: 10.1111/j.1742-6723.2005.00722.x.

    PMID: 15953218BACKGROUND
  • Patel N, Dodsworth M, Mills JF. Cardiac output measurement in newborn infants using the ultrasonic cardiac output monitor: an assessment of agreement with conventional echocardiography, repeatability and new user experience. Arch Dis Child Fetal Neonatal Ed. 2011 May;96(3):F206-11. doi: 10.1136/adc.2009.170704. Epub 2010 Jul 6.

    PMID: 20605971BACKGROUND
  • Geiger S, Stemmler HJ, Suhl P, Stieber P, Lange V, Baur D, Hausmann A, Tischer J, Horster S. Anthracycline-induced cardiotoxicity: cardiac monitoring by continuous wave-Doppler ultrasound cardiac output monitoring and correlation to echocardiography. Onkologie. 2012;35(5):241-6. doi: 10.1159/000338335. Epub 2012 Apr 23.

    PMID: 22868502BACKGROUND
  • Nguyen HB, Banta DP, Stewart G, Kim T, Bansal R, Anholm J, Wittlake WA, Corbett SW. Cardiac index measurements by transcutaneous Doppler ultrasound and transthoracic echocardiography in adult and pediatric emergency patients. J Clin Monit Comput. 2010 Jun;24(3):237-47. doi: 10.1007/s10877-010-9240-6. Epub 2010 Jun 20.

    PMID: 20563629BACKGROUND
  • Van den Oever HL, Murphy EJ, Christie-Taylor GA. USCOM (Ultrasonic Cardiac Output Monitors) lacks agreement with thermodilution cardiac output and transoesophageal echocardiography valve measurements. Anaesth Intensive Care. 2007 Dec;35(6):903-10. doi: 10.1177/0310057X0703500608.

    PMID: 18084981BACKGROUND
  • Smith BE, Madigan VM. Non-invasive method for rapid bedside estimation of inotropy: theory and preliminary clinical validation. Br J Anaesth. 2013 Oct;111(4):580-8. doi: 10.1093/bja/aet118. Epub 2013 May 3.

    PMID: 23645929BACKGROUND

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

10ml venous blood will be collected through venipuncture. Blood will be centrifuged, plasma decanted, and stored pending B-type Natriuretic Peptide (BNP) measurements.

MeSH Terms

Conditions

Heart Failure

Interventions

Echocardiography

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Cardiac Imaging TechniquesDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisUltrasonographyHeart Function TestsDiagnostic Techniques, Cardiovascular

Study Officials

  • Timothy H Rainer, MD FCEM

    Accident & Emergency Medicine Academic Unit

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director & Professor

Study Record Dates

First Submitted

November 6, 2014

First Posted

November 13, 2014

Study Start

November 1, 2014

Primary Completion

February 6, 2018

Study Completion

February 6, 2018

Last Updated

February 7, 2018

Record last verified: 2018-02

Locations